Addiction to Nasal Decongestants Based on Α-Adrenoceptor Agonists Case Series and Literature Review

Authors

  • Ana Fulga ”Dunarea de Jos” University of Galati
  • Andrei Zenovia ”Sf. Apostol Andrei” Emergency Clinical Hospital of Galati
  • Doriana Cristea Ene ”Sf. Apostol Andrei” Emergency Clinical Hospital of Galati
  • Constantin Stan ”Dunarea de Jos” University of Galati
  • Dorel Firescu ”Dunarea de Jos” University of Galati
  • Iuliu Fulga ”Dunarea de Jos” University of Galati

Keywords:

nasal decongestant; nasal obstruction; OTC; addiction; psychiatric disorders

Abstract

Otorhinolaryngologists describe nasal obstruction as a common symptom, moreover a prolonged use of nasal decongestants based on α-adrenoceptor agonists lead to a vicious circle of addiction. This addiction is favoured by easy access to this variety of over-the-counter medications, which are often considered risk-free. The patient may experience a spectrum of mental disorders when deprived of the agent of his addiction, which can range from moderate discomfort to panic attacks or even hallucinations. In this article, we present an analysis of a series of cases of patients who chronically abuse nasal decongestants, and a review of the literature.

Author Biographies

Ana Fulga, ”Dunarea de Jos” University of Galati

Faculty of Medicine and Pharmacy, Clinical Department

Andrei Zenovia, ”Sf. Apostol Andrei” Emergency Clinical Hospital of Galati

Department of Otorhinolaryngology

Doriana Cristea Ene, ”Sf. Apostol Andrei” Emergency Clinical Hospital of Galati

Department of Otorhinolaryngology

Constantin Stan, ”Dunarea de Jos” University of Galati

Faculty of Medicine and Pharmacy, Clinical Department

Dorel Firescu, ”Dunarea de Jos” University of Galati

Faculty of Medicine and Pharmacy, Clinical Department

Iuliu Fulga, ”Dunarea de Jos” University of Galati

Faculty of Medicine and Pharmacy, Clinical Department

References

[1] A. G. Debasish Basu, „Substance use and other addictive disorders in international classification of Diseases-11, and their relationship with diagnostic and statistical Manual-5 and international classification of Diseases-10,” Indian J Soc Psychiatry, nr. 34, pp. 54-62, 2018.
[2] E. A. Strecker, Basic Psychiatry, New York: Random House,, 1952, p. p123.
[3] G. W. Blackwood, „SEVERE PSYCHOLOGICAL DISTURBANCE RESULTING FROM ABUSE OF,” Scot Med J, Vol. 1 2175-176, p. 27, 1982.
[4] S. S. SNOW, „Nasal Spray "Addiction" and Psychosis: A Case Report,” Brit. J. Psychiat., nr. 136, pp. 297-299, 1980.

[5] J. S. ANAND, „Misuse of Xylometazoline Nasal Drops by Inhalation,” Substance Use & Misuse, nr. 43, p. 2163–2168, 2008.
[6] R. S. Cartabuke, „Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Use During Nasal Surgery in Children,” The Laryngoscope, pp. 1-7, 2019.

[7] T. Matsumaru, „Comparison of toxicity and toxicokinetics/pharmacokinetics of an alpha 1L-adrenoceptor agonist in rats and rhesus monkeys,” J Pharmacol Sci, nr. 97, pp. 273-283, 2005.
[8] J. K. Yoo, „Extended Use of Topical Nasal Decongestants,” The Laryngoscope, nr. 107, p. 40:43, 1997.
[9] R. C. W. HALL, „Psychiatric reactions produced by respiratory drugs,” PSYCHOSOMATICS, pp. 605-616, 1985.
[10] D. Belin, ADDICTIONS FROM PATHOPHYSIOLOGY TO TREATMENT, Rijeka, Croatia: InTech, 2012.
[11] G. P., „Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity.,” Rhinology, vol. 34, pp. 9-13, 1996.

Downloads

Published

2021-11-18

How to Cite

Fulga, A., Zenovia, A., Cristea Ene, D., Stan, C., Firescu, D., & Fulga, I. (2021). Addiction to Nasal Decongestants Based on Α-Adrenoceptor Agonists Case Series and Literature Review: Array. EuroEconomica, 40(2). Retrieved from https://dj.univ-danubius.ro/index.php/EE/article/view/1455

Issue

Vol. 40 No. 2 (2021)

Section

Entrepreneurial Perspectives

License

The author fully assumes the content originality and the holograph signature makes him responsible in case of trial.